Skip to content

Quest Diagnostics DGX Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Opko Health logo
Opko HealthOPK
Natera, Inc. logo
Natera, Inc.NTRA
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$2.9B+9.2%
Gross profit$942.0M+9.2%
Operating income$399.0M+15.3%
Net income$252.0M+14.5%
EPS (diluted)$2.24+15.5%

Balance sheet

See full
Cash & equivalents$393.0M+109%
Total debt$6.4B-2.5%
Total equity$7.4B+6.3%
Total assets$16.7B+5.5%

Cash flow

See full
Operating cash flow$278.0M-11.5%
CapEx$114.0M-2.6%
Free cash flow$164.0M-16.8%

Valuation

See full
Market cap$23.03B+18.6%
Enterprise value$29.04B+14.0%
P/E22.5×+2.0×
P/S+0.2×

Profitability

See full
Gross margin33.2%+0.4pp
Operating margin14.3%+0.6pp
Net margin9.1%+0.2pp
FCF margin11.8%+1.4pp

Returns & leverage

See full
Return on equity14.3%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's amortization of capitalized software and acquired intangible assets?
Quest Diagnostics (DGX) reported amortization of capitalized software and acquired intangible assets of $37M in Q1 2026.
How has Quest Diagnostics's amortization of capitalized software and acquired intangible assets changed year-over-year?
Quest Diagnostics's amortization of capitalized software and acquired intangible assets decreased by 5.1% year-over-year, from $39M to $37M.
What is the long-term trend for Quest Diagnostics's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Quest Diagnostics's amortization of capitalized software and acquired intangible assets has grown at a 10.6% compound annual growth rate (CAGR), from $103M to $154M.